Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

South Korea · Delayed Price · Currency is KRW

2,435.00

+50.00 (2.10%)

At close: Aug 20, 2026

Kangstem Biotech Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,035	3,572	7,746	12,704	16,301	12,405
Revenue Growth	-60.82%	-53.88%	-39.03%	-22.06%	31.41%	35.75%
Gross Profit	413.99	845.01	4,325	1,643	4,873	2,689
Operating Income	-19,120	-17,668	-14,842	-22,777	-20,558	-22,736
Net Income	-11,572	-10,482	-7,669	-21,949	-20,236	-21,348
Earnings Per Share	-130.92	-150.86	-136.00	-540.61	-533.40	-766.61
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	27,412	38,569	18,267	37,360	36,678	56,585
Total Debt	9,187	9,400	8,456	13,609	13,369	14,044
Net Cash (Debt)	18,225	29,169	9,811	23,751	23,309	42,542
Net Cash Growth	85.77%	197.32%	-58.69%	1.90%	-45.21%	115.13%
Net Cash Per Share	206.18	419.79	173.97	584.98	614.40	1527.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-16,646	-11,676	-18,987	-16,498	-18,864	-16,994
Capital Expenditures	-364.51	-660.84	-593.45	-1,392	-712.42	-4,631
Free Cash Flow	-17,010	-12,337	-19,581	-17,890	-19,576	-21,624
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	13.64%	23.65%	55.84%	12.93%	29.89%	21.68%
Operating Margin	-630.05%	-494.56%	-191.62%	-179.29%	-126.12%	-183.28%
Pretax Margin	-380.85%	-293.00%	-91.44%	-182.13%	-124.02%	-175.83%
Profit Margin	-381.33%	-293.41%	-99.01%	-172.77%	-124.14%	-172.10%
FCF Margin	-560.53%	-345.33%	-252.79%	-140.82%	-120.10%	-174.32%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	75.47	61.08	14.62	10.55	6.74	10.00